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It is generally accepted that the immune system comprises two classes of lym-
phoid cytotoxic effectors, (a) CTL that, upon prior sensitization to antigen, lyse
antigen-bearing cells, such as virally infected cells or allogeneic cells and (b) NK
cells thatlyse, without priorsensitization, certain tumor andvirally infectedtargets.
The fundamentaldifference between NK andCTL is thatthe former's lytic process
is not immunologically specific nor is it restricted by the MHC. The recent finding
that non-MHC-restricted T cells (CD3+) can mediate NK-like activity (1) has led
investigators to reclassify these two effector populations to includeMHC-restricted
CTL, non-MHC-restricted CTL, and NK cells (2, 3). Within each oftheseclasses
oflymphocytes a variety of stimuli can augment lytic activity and/or broaden the
spectrum of target killing, thereby giving rise to a myriad of effectors including:
lectin-activated killer cells (4), anomalous killer cells (AK)1 (generated under mixed
lymphocyte tumor culture (MLTC)conditions) (5) andlymphokine-activated killer
(LAK) cells (6-8). The involvement ofthe lymphokine IL-2 is central to all ofthese
activation events (9-11). IL-2 promotes the growth and differentiation ofboth CTL
and NK cells and under optimal conditions can even stimulate monocytes (12) and
B cells (13). These activated killer cells, as defined by their ability to mediate cyto-
toxiceffectsonabroad spectrum ofNK sensitiveand NK-resistant targets, (including
fresh autologous tumor targets), are thought to be a potential cancer therapy mo-
dality. Extensive study during the past five years has not revealed the precise rela-
tionship among these various cytotoxic cellular components ofthe immune system,
and the heterogeneity contained within each, phenotypically and functionally, has
no doubt complicated matters.
Atpresent, there is some debate as towhetherthe majority ofLAKcells aresimply
lymphokine-activated naturalcells (LANKcells) (14)orwhether they representsep-
arate lineages ofcytotoxic cells. Many investigators claimthat only the Leu-11 (IgG
Fc receptor) or NKHI (Leu-19) positive lymphocytes (which include the resident
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population ofPBL that mediate true NK cytotoxicity) can give rise to LAK effectors
in the presence of IL-2 (15-18) . This is in contrast to the original work by Grimm
et al. (19) stating that the LAK precursor (LAKp) cell(s) has no surface markers
identifiable by currently available antisera against differentiation clusters (e.g. CDl,
CD2, CD3, CD4, CD5, CD8, CD16, CD25). Although LAK activity can be gener-
ated from a cell population that morphologically belongs to the large granular lym-
phocyte (LGL) subset ofPBL, a number of investigators have observed that rigorous
treatment of PBL with anti-NK antibodies and rabbit complement (to remove the
cells that mediate NK activity) has little effect on LAK generation (19-21). In addi-
tion LAK cells can be generated from lymph nodes, thymus, and the thoracic duct
which have minimal, if any, NK activity (22).
The relationship between LAK cells and CTL is somewhat clearer. The genera-
tion ofallospecific CTL can be totally abrogated by treating PBL with pan-T mAbs
followed by negative FAGS sorting or complement-mediated lysis (23). Such treat-
ment, however, does not affect the development of LAK effector cells and may in
fact augment their generation (24). This distinction between LAK cells and specific
CTL, however, can be overcome at the effector level if high concentrations of IL-2
are administered during MLC (25), thereby, generating nonspecific CTL that func-
tionally behave as LAK effectors. It has also been shown that a subpopulation of
T cells (CD3+) can mediate non-MHC-mediated cytotoxicity and that this popu-
lation may contribute to the total LAK potential found in PBL (26). Further, cells
of a more primitive lymphocyte lineage (CD3- , CD2- ) can be induced to undergo
differentiation into mature LAK effectors (27), illustrating the heterogeneity ofcell
types that are able to generate LAK-like activity.
In the present paper we have investigated the relationships between the LAK
phenomenon and various other cytotoxic effector cell systems by generating mAbs
directed against a cell population that can be induced to become LAK effectors in
the presence ofIL-2 and autologous serum. Depletion of the cells expressing deter-
minants recognized by these antibodies reduces LAK generation appreciably, while
leaving NK activity relatively intact. Further, these antibodies have little effect on
the generation of either specific CTL or MLTC induced NK-like activity. These
findings indicate that LAK cells are not necessarily derived only from mature NK
or T cells, but can also be generated from a third population of cells that share a
common surface marker. These cells may be identical to, or include, the NK precursor
cell .
Materials and Methods
Preparation ofPBL.
￿
Venous bloodwas collected from normal donors in heparinized Vacu-
tainer tubes. Mononuclear cells were prepared by centrifugation over Ficoll-Isopaque (Phar-
macia Fine Chemicals, Dorval, Quebec) and unless otherwise indicated, were depleted of
monocytes by incubation on plastic for 1 h at 37°C. This nonadherent cell population is re-
ferred to simply as PBL.
Media and Reagents.
￿
Media used to culture cell lines consisted of RPMI 1640 containing
10% FCS and 10 MM L-glutamine. Media used for the generation of CTL, AK, or LAK
cells consisted ofculture media without FCS, supplemented with 10% autologous serum or
10% pooled human AB serum. Affinity-purified IL-2 was used at a concentration of 10%
(Biotest, Fairfield, NJ) or rIL-2 at 30 U/ml (Amgen, Thousand Oaks, CA) or 1,000 U/ml
(a kind gift from Cetus Corp., Emeryville, CA).
Cell Lines.
￿
PR1, an EBVlymphoblastoid cell line (LCL), was derived by infecting lym-MORRIS AND PROSS
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phocytes with virus preparations from the B95-8 cell line, as previously described (28). The
maintenance and relative NK sensitivity of K562, an erythroleukemic cell line and Rail,
a Burkitt's lymphoma cell line have been described previously (29). Cultures were fed three
times weekly and periodically tested for mycoplasma contamination by DAPI (4,6-diamidino-
2-phenylindole) (Sigma Chemical Co., St. Louis, MO) staining (30).
Monoclonal Antibodies.
￿
The following mAbs were used: Leu-11b (CD16), anti-IL-2R (CD25)
(Becton Dickinson & Co., Mountain View, CA), OKT8 (CD8), OKT11 (CD2), and OKMl
(CR3) (Ortho Diagnostics, Raritan, NJ). AntiTac (IL-2R) was a gift from Dr. T Waldmann,
National Institutes of Health (Bethesda, MD). BBMI (N2-microglobulin), L243 (class 11
framework), W632 (class I framework), and OKT3 (panT) were grown as ascites from hy-
bridomas obtained from the American Type Culture Collection (ATCC; Rockville, MD).
The hybridomas DM-1 and DM-2 described in this report have been deposited with the ATCC
(Numbers HB 9691 and HB 9692, respectively).
Percoll Gradients.
￿
Approximately 108 PBL were layered onto a seven-step Percoll (Phar-
macia Fine Chemicals, Uppsala, Sweden) discontinuous gradient consisting of 1.5-ml layers
of 42 .5, 45.0, 47.5, 50.0, 52 .5, 55.0, and 66.7% Percoll, adjusted to 285 mOsm/kg H2O with
10x PBS, pH 7.3, before use. The conditions for gradient centrifugation were specifically
defined so as to maximize the separation ofLAKp and mature NK cells (see Results), similar
to that described by Grimm et al. (6). Morphologic data were obtained from cytocentrifuged
methanol-fixed Giernsa-stained cells. The cell-sorting experiments used a modified three-
step gradient (45, 50, and 55% Percoll) to facilitate LAKp enrichment.
mAb Generation.
￿
6-8-wk-old BALB/c female mice were injected with 1-2 x 10' Percoll
enriched LAKp cells intraperitoneally four times at -2-wk intervals. Fusion of spleen cells
to the murine fusion partner SP2/0 Ag14 (non-Ig producer) took place afterthe fourth injec-
tion using standard hybridoma methodology (31, 32). Hybridoma supernatants were screened
by ELISA on glutaraldehyde (Sigma Chemical Co.) fixed PBL or fixed Percoll enriched frac-
tion cells, both of which were obtained from a donor HLA-unrelated to the donor whose
cells were used for immunization. All positive hybridomas were grown as ascites in nude
mice after they had been cloned at least three times. Isotyping of selected antibodies was
done using an ELISA-based Isotyping kit (Boehringer Mannheim, Dorval, Quebec).
Complement-mediated Lysis.
￿
PBL were incubated with undiluted hybridoma supernatant
or a 1 :20 dilution of hybridoma ascites for 1 h at 4°C, washed once, and then incubated
for 1.5 h at 37°C with a 1:5 dilution of LowTox rabbit complement (Cedarlane Laboratories
Ltd., Hornby, Ontario) that had been screened for high lytic titer and low nonspecific tox-
icity. Dead cells were scored using the trypan blue exclusion test after the cells had been washed
twice.
Panning.
￿
35 x 10 mm petri plates were coated with 3 hg/ml goat anti-mouse (GAM) Ig
(Cappel Laboratories, Malvern, PA) in Tris-HCI, pH 9.0, for 2 h at 4°C and then washed
extensively. PBL (101 cells) that had previously been incubated with hybridoma supernatants
for 1 h at 4°C were then incubated on the antibody-coated plates for 1 h in a 37°C, 5%
C02 incubator. The nonaherent cells were collected by gently washing the plates with cold
PBS, pH 7.3 . The adherent cell population was collected by vigorous pipetting. The sepa-
rated populations were washed twice with media before use and analyzed using flow cytom-
etry to monitor the efficiency of the separation. In all cases the efficiency was >90% .
Indirect Immunofluorescence.
￿
106 cells were incubated with hybridoma supernatant or a di-
lution of the corresponding ascitic fluid for 1 h at 4°C, washed twice and then further in-
cubated with a 1 :20 dilution of a FITC-conjugated GAM Ig (Boehringer Mannheim Bio-
chemicals) or FITC-conjugated (Fab')2 GAM Ig (Cappel Laboratories) for 1 h at 4°C. Cells
were washed three times and layered on to 0.5 ml of FCS and centrifuged at 200 g. The FCS
was aspirated offand the pellet was resuspended in 0.5 ml of RPMI 1640 containing 5% FCS
and analyzed on a FACS IV (Becton Dickinson & Co., Mountain View, CA).
Cell Sorting .
￿
Cells (2 x 106/ml) labeled with DM-1 (indirect FITC label) were sorted into
positive and negative populations at a flow rate of -1,500 cells/s into collection tubes con-
taining 1 ml of RPMI 1640, 10% autologous serum, and 100 l~g/ml gentamycin on ice.
LAK Cell Generation.
￿
PBL isolated as described above were activated to generate LAK
cells by in vitro incubation for 7 d in RPMI 1640, 10 MM L-glutamine, 10% autologous serum,
and 30 U/ml rIL2 (Amgen), or 1,000 U/ml rIL-2 (Cetus Corp.) or 10% highly purified IL2720
￿
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(Biotest). Cells were incubated at a concentration of 2 x 106/ml in T25-cm2 tissue culture
flasks (Corning Glass Works, Corning, NY) or in 13-ml tubes (Falcon Labware, Oxnard,
CA) in a 59o C02, 37°C environment. The use of rIL-2 or highly purified IL-2 made little
difference on proliferation or cytotoxic response.
MLC and AK Cell Generation.
￿
Before the addition of the responder lymphocytes, the
stimulating lymphocytes (MLC assay) or tumor cell lines (AK assay) were x-irradiated at
an air-dose rate of 4.7 Gy/min for 13.5 min using a superficial x-ray machine (model RT100,
Philips Electronic Instruments, Inc., Mahwah, NJ). The optimal stimulator-to-responder
ratio was predetermined for each stimulator and was found to be 1 :5 for the tumor stimu-
lators and 1 :2 for the allogeneic lymphocyte stimulators. The mixed cultures were then in-
cubated in 24-well plates at a concentration of 2 x 106 responders/ml in RPMI 1640 con-
taining 10% responder autologous serum or pooled AB + serum. Cultures with responders
and stimulators alone were set up as controls. To assess the proliferative response of responder
lymphocytes during the co-culture period, 106 cells were removed on day 6 and seeded in
96-well flat-bottomed microtiter plates. 1 1Ci of [3H]thymidine (1 mCi/ml; New England
Nuclear, Boston, MA) was added to each well, and the total volume was made up to 100 pl
with RPMI 1640 containing 10% AB serum. Cultures were harvested 18 h later by means of
a harvester (Skatron, Inc., Sterling, VA) on fiberglass filters and DNA isotope incorporation
was measured using a liquid scintillation counter. All data are presented as mean cpm ±
SD of incorporated [3H]thymidine from 12 replicate wells.
Cytotoxicity Assays.
￿
NK and LAK activity were assessed in an 18-h "Cr-release assay
against the targets K562 (NK-sensitive, LAK-sensitive) and RAJI (NK-resistant, LAK-
sensitive) as described previously (29). Percent specific release was calculated as follows: per-
cent specific release = 100 x {[cpm (test) - cpm (medium)]/[cpm (max) - cpm (medium)]}.
All chromium release data were expressed in lytic units, defined as the number of effectors
required to lyse 1,000 target cells (LU (20%)/106), calculated according to the equationy
= A(1-e
kx), where y is fraction chromium release, x is lymphocyte-target cell ratio, k is a
constant proportional to effector cell number and equal to the negative slope of the target
cell survival curve obtained by plotting 1n(Ay) vs. x, and A is the maximal cell mediated lysis.
Western Blots.
￿
To characterize the moiety recognized by the mAb generated, Western blots
were performed on unseparated PBL membrane preparations as described below. Briefly,
109 nonadherent cells were incubated on ice for 30 min in membrane buffer (0.117o BSA, 1
MM MgC12, 0.1 mM PMSF, 0.01 M Tris-HCI, pH 7 .6, 1 mM iodoacetamide), homogenized
in a dounce homogenizer (16 strokes), and centrifuged for 10 min at 4,000 g at 4°C. The
supernatant was recovered and made up to 13 ml in membrane buffer and centrifuged for
1 h at 55,000 g at 4'C. The pellet was then resuspended in 200 P1 of storage buffer (0.15
M NaCl, 5 mM EDTA, 50 mM Tris-HCI, pH 7.5, 0.02% NaN3). 50 p.l of this membrane-
containing solution was added to 10 pl ofelectrophoretic sample buffer (0.0625 M Tris-HCI,
pH 6.8, 1% SDS, 10% glycerol, 2% 2-ME, 0.001% bromophenol blue, 0.1 mM PMSF) and
run on a 4.5%/12.0% SDS-PAGE according to the method of Laemmli (33). The lanes of
interest were blotted on to nitrocellulose membranes using a Bio-Rad Laboratories (Rich-
mond, CA) transmembrane blotting apparatus and carbonate buffer system (10 MM
NaHC03, pH 9.9, 3 mM Na2CO3, in 20% methanol) after soaking the gel in 3% gelatin,
Tris HCl, pH 7.2, for 1 h. After a 3-h transfer at 250 mA the membrane was blocked in
5% normal goat serum, 1% BSA, 3% gelatin in TBS (20 mM Tris-HCI, 500 mM NaCl,
pH 7.5) overnight with shaking at room temperature and then incubated with hybridoma
supernatant or diluted ascites for 4 h at room temperature on a rocker platform. The mern-
brane was washed three times for 10 min in TTBS (0.05% Tween 20 in TBS) and incubated
with a 1 :2,000 dilution of GAM Ig-horse radish peroxidase (HRP) (Boehringer Mannheim)
for 2 hrs. After four 10-min washes in TTBS, the 4-CN (4-chloro-l-naphthol) (Sigma Chem-
ical Co.) substrate was added and allowed to develop in the dark for 30 min. The reaction
was stopped by rinsing the nitrocellulose membrane in distilled water.
Results
Separation ofMature NK Cellsfrom LAK Precursor Cells.
￿
PBMC collected from normal
individuals and depleted of adherent cells on plastic were fractionated on a seven-MORRIS AND PROSS
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step Percoll discontinuous gradient . To increase the concentration of LAKp cells
relative to NK cells, a modification of the original method of Percoll fractionation
described forNK enrichment byTimonen andSaksela (34) wasundertaken in which
the gradient was centrifuged for a longer time (45 min) and at a lower centrifugal
force (300g) . The separation ofmature NK cells from LAKp cells that can be achieved
on such a gradient is illustrated in Fig. 1 . By comparingNK activity at day 0 with
LAK activity at day 7, in each respective fraction, it is apparent that these popula-
tionscan be separated from each other according to densities . With regard to K562
cytotoxicity (Fig . 1 A), most of the NK activity was found in fraction 2 (45% Per-
coll), whilemost oftheLAKpotentialwas found in fractions 3 and 4 (47.5 and 50 .0 0 /0
Percoll, respectively) . Similarly, when cytotoxicity against theNK resistant cell line
RAJI (B) was examined at day 7 these same two fractions showed the highestLAK
activity. The proliferation potential of the various fractions shown in Fig . 1 is an
index relative to the number of cells in each fraction originally cultured in IL-2 .
From this figure it is evident that fraction 3 contained thehighest proliferative potential.
The percentage of total lytic units found in each fraction, (taking into account the
cell yield of each fraction), both atDay 0(NK) and at Day 7 (LAK) is given in Table
1 . It is interesting to note that the highest percentage of total lytic units of all six
fractions atDay 0 isfoundin fraction 3 (47.5% Percoll) not in fraction 2, as it would
have been if cell yield per fraction had not been taken into account . This indicates
that although fraction 2 has ahigher proportion ofNK activity (either greaternumbers
of functionalNK cells or simply more active NK cells), fraction 3 has greater total
activity. Aftersevendays in IL-2 culture, thePercoll fraction that exhibited the highest
LAK effector activity in addition to the highest total lytic units of all cell fractions
FIGURE 1 .
￿
Percoll gradient separation ofLAK
progenitors from mature NK cells . -10s cells
were layered on a seven-step Percoll gradient
(42.5-66.7%, fractions 1-6, respectively) andspun
for 45 min at 300g . Each fractionwas then tested
forNK activity and set up at 2 x 106 cells/ml in
5ml ofculture media containing 10% autologous
serum and30 U/ml rIL-2 . Cytotoxicity vs .K562
(A) and Raji (B)offractionated PBL atday0(Q)
and after incubation with IL-2 for 7 days (®) is
expressed in LU (20%)/106 cells. Cell yield on
day 7 (-*-) is given as a proliferation index rel-
ative to the number of cells originally cultured .
Data are representative ofthree separate experi-
ments . The standard deviation ofthe lytic unit
values did not exceed 15% .722
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TABLE I
Percent of Total Lytic Units of Individual Percoll Fractions at Day 0
(NK Activity) and at Day 7, after IL-2 Incubation (LAK Activity)
Cells from Percoll fractions (generated as described in Fig. 1) and PBL were
set up in IL-2 culture at a concentration of 2 x 106 cells/ml in T25-cm2 flasks
containing RPMI 1640, 10% autologous serum, and 30 U/ml rIL-2 . The flasks
were incubated for 7 d at 37°C in a 5% C02 incubator. Cells were removed,
washed twice, counted for viability, and set up in a 5'Cr-release assay. Cell yield
from the gradient was routinely 85 % of the number of cells originally put in
(including the cell pellet, fraction 7). Numbers in bold face indicate maximum
NK activity (fraction 3) and maximum LAK activity (fraction 4).
was fraction 4. This indicates that at day 0, fraction 4 contained the highest relative
proportion of LAKp cells as well as the highest absolute number of LAKp, while
at the same time expressing relatively little NK activity.
PercollFraction Phenotype.
￿
To examinethe phenotypic markers on thecells in each
fraction, FACS analysis using a battery of mAbs was undertaken (Fig. 2). It was
apparent that there is enrichment ofLeu-11b' cells in fractions 2 and 3 representing
most of the FcR' LGL in the upper fractions (Fig. 2 A). The staining pattern of
OKT11 on PBLand the various Percoll fractions is shown (Fig. 2 B). PBL and frac-
tion 6 contained -80 and 87% OKT11 + cells, respectively, whereas fractions 1 and
2, and 3 (combined) all contain <50%. OKT 3 showed a similar pattern to OKTll,
staining 83% ofPBL and 86%v offraction 6, while staining the less dense fractions
onlymoderately. OKMI stained 18% ofPBL but showed increased staining in frac-
tions 2 and 3 (47%).
Production ofmAbs to Pre-LAK Cells.
￿
Cells from Percoll fraction 4 were injected
into 6-8-wk-old female Balb/c mice. OftheN1,650resultant hybridomas that reacted
withfraction4lymphocytes, twohybridomas produced mAbsthat reactedwithcells
that were required for LAK cell generation. These mAbs (DM-1 and DM-2) are
bothcapable ofdepletingacell population required forthe generationofLAK effectors
asjudged by cytotoxic ability at day 7 after IL-2 incubation. These antibodies are
described below.
Day 0 LU(20%)/106 Total cells LU (fraction) Total LU
%
PBL 22
F1 (42.5%) 19 9.0 137 8 .7
F2 (45%) 125 2.4 240 15 .3
F3 (47.5%) 98 8.7 682 43 .4
F4 (50%) 22 22.0 387 24.6
F5 (52.5%) 5 26.4 105 6 .6
F6 (53%) 4 6.8 21 1 .3
Day 7 ( + IL-2)
PBL 250
F1 (42.5%) 20 9.0 144 0 .8
F2 (45%) 290 2.4 557 3 .0
F3 (47.5%) 500 8.7 3,480 18.7
F4 (50%) 550 22.0 9,680 51 .9
F5 (52.5%) 190 26.4 4,013 21 .5
F6 (5557o) 140 6.8 762 4.0MORRIS AND PROSS
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FIGURE 2 .
￿
FRCS analysis ofPBL and Percoll gradient fractions 1, 2 and 3, 4, and 6 stained
with the mAbs Leu-11 (CD16) (A), OKT11 (CD2) (B), OKT3 (CD3) (C), OKMl (CR3) (D).
10 6 cells were incubated with antibody for 1 h at 4°C, washed twice, and then incubated further
with FITC GAM Ig for 1 h at 4°C . Cells were washed three times, layered onto 0.5-ml FCS,
and spun . The FCSwas aspirated off and the cells were resuspended in 0.5 mlRPMI and ana-
lyzed on a FAGS . The y-axis represents the number of cells and the x-axis represents relative
fluorescent intensity. Background histograms (dotted lines) represent class-specific mAb controls
and, to facilitate discrimination, any events above background have been shaded .
FunctionalAssays UsingDM-1 andDM-2.
￿
To characterize thelineage andfunction
of the cell type(s) recognized by these two antibodies (both IgM, k), experiments
usingPBL depleted ofDM-1 + or DM-2 + cells were conducted . Figs . 3 and 4 illus-
trate the effect of usingcomplement and antibody depletion (Fig . 3) and a panning
separation technique (Fig . 4), on NK, LAK, andAK activity. The effect of Leu-11
(CD16), OKT11 (CD2), or OKT3 (CD3) depletion was also examined to monitor
NK andT cell involvement . The results shown in Fig. 3 indicate that depletion of
DM-1' or DM-2+ cells had little effect on NK (K562) or AK (K562 and RAJI)
activities, but markedly reduced LAK generation, whether measured using K562
or RAJI target cells . Theparallel effectsofDM-1 andDM-2 depletiononLAKgener-
ative potential indicate that the two markers are coexpressed on most of theLAK
precursor cells . Conversely, Leu-11 treatment depleted NK activity and to an extent
AK activity, but had little effect onLAK generation by day 7 . Treatment withOKT11724
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FIGURE 3 .
￿
The effect ofantibody
plus rabbit complement on NK,
LAK, andAK (co-culture with the
lymphoblastoid cell line, PR-1) ac-
tivities when PBLwere treated on
day 0 . Briefly, 10 7 PBL were incu-
bated with antibody for 1 h at 4°C,
washed once, and resuspended in
100 ,al prescreened rabbit comple-
ment and incubated for 1hat 37°C .
1 h later an additional 100 Wl of
the complement was added, then
washed twice before use. Data are
representative offour separate ex-
periments. The standard devia-
tion in lytic unit values did not ex-
ceed 15% .
andOKT3 antibodies hadminimal effect onNK (K562) andLAK(K562 and RAJI)
lysis but reduced AK generation (K562 and RAJI) . In all cases, the effect of cell
depletion using the panning method (Fig . 4) was found to be similar to the comple-
ment plus antibody treatment of PBL .
It should be noted that when lytic activity is unchanged after depletion of cells
with a particular marker, the proportion of killer cells with that marker is approxi-
mately equal to the proportion of marker-bearing cells in the original population,
due to the fact that the treated cells are resuspended before the cytotoxicity assay
at the same concentrations as the control cells, which enriches for the non-marker-
bearing killer cells (see formula in reference 35). In thecase ofNK activity, thedata
in Figs . 3 and 4 are compatible with the NK effector cells being -80% OKT11+,
90% Leu-11 *, 5% DM-1', and 157o DM-2', based on the marker proportions ob-
served in unfractionated PBL (see below) and the fact that Leu-11 treatment removed
virtually allNK cytotoxicity . The lack ofenhancement ofNK activity with OKT3+
cell depletion in this particular experiment is unexplained . The formula is not ap-
plicable to the calculation of the proportion of marker-bearing cytotoxic precursor
cells, since there is not necessarily a direct relationship between precursor number
at day0andeffector number at day7. Thedata do indicate, however, thatasignificant
proportion of LAKp or LAKp accessory cells bear the DM-1 andDM-2 markers .2oo, A
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FIGURE 4.
￿
Effect ofpanningdepletion
of PBL pretreated with the indicated
antibodies on NK andLAKactivities.
Petri plates were coated with 3 ug/ml
GAM Ig for 2 h andthen washed six
times. 101 PBL that had previously
been incubated with antibody for 1 h
were then incubatedwith theplates for
2 hat 37°C. Thenonadherentpopula-
tion was recoveredviagentle washing
and the adherent population was re-
moved by vigorous pipetting. Data are
representative-ofthree separate experi-
ments.The standard deviationin lytic
unit values did not exceed 15%.
When DM-1' or DM-2' cells were depleted from PBL and the resulting popu-
lation set up in an AxB,, MLC, little reduction in cytotoxicity generated against
the stimulator cell target (B), K562 or RAJI occurred (Table II). However, when
OKT8' (CD8) or OKT3' (CD3) cells were depleted from PBL and then set up
in anidenticalculture, amarked decrease in cytotoxicity againstthe stimulatortarget,
as well as K562 and RAJI, was observed. The proliferative responsegenerated during
the MLC, as measured by [3H]thymidine uptake, is shown in Table III. Only pre-
treatmentwith theOKT3 andOKT8 mAbaffected theproliferative response. Pretreat-
ment with DM-1 or DM-2 did not have any appreciable effect.
Cell Sorting .
￿
Positive selection ofDM-1' cellswas undertaken to provide evidence
that DM-1 reacts with LAKp cells and not with an accessory population required
for LAK cell generation. Fig. 5 represents the flow cytometric histograms ofPBL
and modified(three-step) Percoll gradient fractions 1 (45%), 2 (50%), and 3 (55%).
The cells found in Percoll fraction 1 provided an enriched DM-1' population for
cell sorting into positive and negative populations. Unstained and irrelevant mAb
control-treated cellswere used toestablish fluorescence parameters. Thelowfluorescent
staining ofDM-1 (Fig. 5) made the inclusion ofhighly autofluorescent cells within
the positive sort window unavoidable. Upon reanalysis, 60% DM-1' cells and 40%72 6
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TABLE II
Cytotoxicity Generated during an A x BX MLC
Responder
A + Control Ab
A + DM-1
A+DM-2
A+OKT8
A+OKT3
A+Leu-11
A + Control Ab
￿
-
￿
12 +_ 6
￿
3 +_ 1
￿
-
￿
-
_
￿
B
Responder lymphocytes (8 x 106 cells) that had been treated with antibody plus complement
were mixed with irradiated (x) stimulator lymphocytes (4 x 106 cells) in 24-well plates that
contained 2 ml RPMI plus 10% responder autologous serum . The plates were incubated for
7 d in a 5% C02 incubator at 37°C . On day 7 the cells were washed twice, counted for via-
bility, and set up in a S'Cr-release assay (LU[20%]/106 t SD). Cultures containing responders
and stimulators alone were set up as controls. The reverse B x Ax results were similar.
low fluorescent or negative contaminating events were found in the positive sorted
population.
The sorted populations were then evaluated for NK and LAK cytotoxic potential
using a "Cr-release assay (Table IV). There was a slight increase in lytic unit values
when the NK activity of PBL was compared with the unsorted Percoll fraction 1
(73 ± 1 to 83 ± 2, respectively). However, substantial NK augmentation occurred
when fraction 1 was depleted of DM-l' cells (114 ± 5 LU). Conversely, the DM-1'
population harbored relatively low NK activity (17 ± 1 LU) . The LAK activity
generated after 5 d of IL-2 incubation was highest in the DM-1+ population (2,556
± 260 LU) as compared with the DM-1 - population (387 ± 48 LU). The DM-1+
population exhibited more LAK activity than did unfractionated PBL or the un-
sorted fraction 1 population. The results of these positive sort experiments indicate
TABLE III
Proliferation Generated during A x Bx MLC
as Measured by C 3HJThymidine Uptake
Responder
￿
Stimulator
￿
cpm
A + Control Ab
￿
B
￿
8,031 ± 1,630
A + DM-1
￿
B
￿
7,586 ± 1,787
A + DM-2
￿
B
￿
6,369 ± 977
A + OKT8
￿
B
￿
4,386 ± 697
A + OKT3
￿
B
￿
1,413 ± 335
A + Leu-11
￿
B
￿
9,749 ± 1,814
A + Control Ab
￿
B
￿
600 +_ 128
-
￿
B
￿
41+27
Cells were removed from the MLC cultures (see Table 11 legend) on day 6 and
seeded into 96-well flat-bottomed microtiter plates (106 cells). 1 JIC [3H]thymi-
dine was added to each well and the total volume was made up to 0.1 ml. Cul-
tures were harvested 18 h later on fiberglass filters and DNA isotope incorporation
measured. (Data presented as mean cpm ± SD of 12 replicate wells.)
Stimulator K562
Targets
RAJI A B
B 148 t 62 210 t 62 11 ± 7 44 ± 19
B 135 ± 44 191 t 54 9 f 2 39 ± 22
B 140±34 170±50 12 ± 3 41 ± 19
B 21 ± 7 14±3 8± 1 2 f 1
B 53± 11 31 ±9 6± 1 5± 1
B 115±31 185±49 9±2 53±29MORRIS AND PROSS
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FIGURE 5 . FRCS analysis of
PBLand modified (three-step)
Percoll gradient fractions 1,
2, and3 (45, 50, and55% Per-
coll, respectively) .The cellsand
data were treated as they were
in Fig . 2 . The gates used to
separate DM-1' from DM-1 -
cells are indicatedby thearrows
on the x-axis of the fraction 1
histogram .
that DM-1+ cells areLAK precursor cells and are not simply accessory cells neces-
sary for LAK generation .
DM-J' andDM-2' Cells during LAK Generation .
￿
The frequency with which DM-1
andDM-2 stain fresh PBL can be seen in Fig . 6 . DM-1 stains 2-15%, andDM-2
15-30% ofPBL . These numbers closely parallel thepercent dead cells observed after
DM-1 andDM-2 depletion using the respective antibody and complement . When
expression ofDM-1 andDM-2 during LAK activation was examined (Fig . 6), both
antibodies recognized cells present at day 0 but over the 8-d IL-2 activation period
there was a gradual loss of these markers . In contrast, the proportion of Leu-11
cells was moderately increased, as expected . The expression ofOKT3 andOKT11
was essentially unchanged during the activation period.
Western Blot Analysis.
￿
To characterize the antigens recognized by these two anti-
bodies, Western blot analysis ofmembrane preparations ofPBL were undertaken .
DM-1 recognizes a 38,000 dalton protein and DM-2, a 44,000 dalton protein on
reducing SDS-PAGE (Fig. 7) .
Discussion
Normal human PBL are capable of several cytotoxic functions mediated by a di-
verse array of effectors, namely thefunctionally definedNK cells (36), MHC-restricted
CTL that recognize targets viaaCD3/Ti antigen receptor structure (2), non-MHC-
restricted CTL that recognize MHC- targets also via CD3/Ti (3), non-MHC-
restricted CTL that recognize targets viaa CD3-associated molecule different from
theTi molecule (37), lectin-activated killer cells (4), killer cells generated underMLC728
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TABLE IV
Cytotoxicity Exhibited by DM-1+ and DM-1- Cell Populations
after Cell Sorting
Fraction 1 cells obtained from a modified three-step Percoll gradient (45, 50,
and 55% Percoll) were sorted into DM-1' and DM-1- populations by flow
cytometry (2 x 106 cells/ml at a flow rate of 1,500 cells/s) . The resultant popu-
lations were tested immediately for NK activity and reanalyzed for percent
DM-1' cells . LAK activity was assessed after 5 d incubation with 1,000 U/ml
rIL-2 (Cetus Corp .) . Cytotoxicitywas measured against the K562 target in a
S'Cr-release assay for 18 h (LU(20%1/10 6 f SD) . Data are representative of
two separate experiments .
FIGURE 6 . FRCS analysis of
PBL stained with the mAbs
DM-1, DM-2, OKT11, OKT3,
and Leu-11 at day 0, 4, and 8
of incubation with IL-2 . The
cells and data were treated as in
Fig . 2 .
Cell population DMA' NK
LU(20 % )/106
LAK
0 /0
PBL - Unfractionated 4 73 ± 2 1,310 ± 104
Fraction 1 - Unsorted 21 83 ± 6 1,807 ± 190
Fraction 1 - DM-1` (sorted) 62 17 f 1 2,556 t 260
Fraction 1 - DM-1 - (sorted) 1 114 ± 5 387 ± 48
Fraction 2 - Unsorted 7 72 +_ 3 702 +_ 88
Fraction 3 - Unsorted 2 12 + 1 266 + 54MORRIS AND PROSS
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FIGURE 7 .
￿
Western blot analysis ofDM-1 and
DM-2 antigens from PBL . Membrane-con-
taining preparations were run on SDS-12%
polyacrylamide gels (33) and transferred to
nitrocellulose. DM-l +andDM-2'bands were
visualized usingaHRP-4CN system (as out-
lined inthe Materials andMethods). (Lane 1)
Molecularweight markers; (lane 2) Coomas-
sie-Blue-stained gel ofPBLmembrane prep-
aration; (lanes 3 and 4) DM-1 and DM-2-
stained transfers of lane 2, respectively.
orMLTC conditions, i.e .,AK cells (5), and finally, LAK cells (8) . The relationships
among these effector cells remain elusive despite considerable research (38) . In the
present study we have investigated the relationship between NK, LAK, AK, and
CTL at the level of their precursors . The experiments described were undertaken
to isolate a cell population that was neither a mature NK cell norT cell, and could
be induced by IL-2 alone to become mature LAK cells . This was done in two ways :
(a) by the Percoll gradient separation of mature NK cells from a population of cells
that generates maximalLAK potential upon exposure to IL-2 and (b)by theproduction
ofmAbs that react with these Percoll-enriched LAKp but not with mature NK cells
or other cytotoxic lymphocytes . The argument that mature NK cells are the sole
progenitors ofLAK effectors isweakened by the finding that treatment ofPBL with
several anti-NK antibodies has only amoderate influence onLAKeffectors or their
precursors (20, 21) . Further, LAK activity can be generated from various lymphoid
tissues that are devoid ofNK activity (22) .
In the past, using standard Percoll separation techniques, most LAK activity has
been generated from those LGL populations that also contained peak NK activity.
We have shown that by varyingcentrifugation conditions from those used for stan-
dard LGL enrichment (34), the separation of cells mediatingNK activity (fractions
2 and3) from cells that exhibit maximalLAKactivation (fraction 4) can be achieved
(Fig . 1) . It is of interest to note that the proliferative response to IL-2 did not peak730
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in fraction 4, where maximal LAK potential resided, but peaked in the less dense
fraction 3. Two possible explanations may account for this. First, other cells found
in fraction 3, which are not cytotoxic to the targets K562 and RAJI, are prolifer-
atingin response to IL-2, thus resultingin increased proliferationwithout increased
cytotoxicity. A second possibility is that thecells in fraction3, although proliferating
to a greater extent, are less cytotoxic on a per cell basis than are cells in fraction
4, thus suggesting that heterogeneity exists amongthose cells that becomecytotoxic
upon exposure to IL-2.
This partial separation of LAKp and NK effectors on Percoll gradients has al-
lowed us to examine a population of IL-2-reactive lymphocytes in isolation from
the majority ofcells mediating NK activity. mAbs were generated after immuniza-
tion with these cells to further characterize the relationship offraction 4 cells and
LAKp cells. Two antibodies, DM-1 andDM-2 (both IgM,k), were chosen fromthose
antibodies that react with fraction 4 lymphocytes for further study because oftheir
specificity for a cell population that generated LAK effectors upon incubation with
IL-2. The incubation of PBL with either of these two antibodies followed by
complement-mediatedlysisor panning, decreased LAKeffector generation markedly,
and formed the basic strategy for the preliminary functional screening.
The possibility that these mAbs react with an accessory population required for
LAK effector generation, and not LAKp cells, cannot be excluded using negative
selection techniques. Therefore, positive cells were sorted using flow cytometry to
provide evidence that the DM-1 mAb does react directly with LAKp cells and not
with an accessory cell population. To enrich the numberofDM-1' cells in thepopu-
lation to be sorted, a three-step Percoll gradient was used (Fig. 5). Fraction 1 of
the gradient was routinelyenriched 10-foldoverunseparatedPBL. Afterincubating
the sorted populations in Il-2 for 5 d, the DM-1' sorted population exhibited al-
most a sevenfold increase in cytotoxicity over the DM-1- fraction. The enrichment
for LAKp cells found in this fraction was also demonstrated by the 1.4-fold increase
in cytotoxicity over unsorted fraction 1 cells. When the NK activity ofthese sorted
populations was examined the DM-1' fraction exhibited minimal NK activity com-
pared with the DM-1- fraction (7-fold higher) and unsorted Percoll fraction 1 (1.5-
fold higher). Based on the enrichment ofDM-1' cells, in associationwith markedly
increased LAK generative potential, it is unlikely that the effects seen are due to
contaminating DM-1- cells. This apparent contamination could have been due to
modulation oftheDM-1 antigen, ungated cell debris resultingfrom the sortingpro-
cedure, and/or thechoice ofgates necessary to include relativelylow fluorescent DM-
1' cells allowing inclusion of some highly autofluorescent events (Fig. 5).
The knowledge that a variety of lymphocytes (CD4' T cells, CD8' T cells,
CD20' B cells, CD2- CD16- CD20- null cells and CD16' Leu-19' NK cells) can
give riseto LAKactivity (10), coupled with the fact that DM-1 and DM-2 onlyreact
with N2-15 and 15-30% of PBL, respectively, raises obvious questions. If all the
above cell types can give rise to LAK effectors then an antibody that reacts with
the majority ofLAK precursors must reactwith some orall ofthese cell types. Two-
color double'-marker analysis of DM-1' and DM-2' cells is currently in progress
usingHPLC-purified, FITC-labeled DM-1 and phycoerythrin-labeled Leu-11b, Leu-4,
and Leu-19 antibodies (Morris, D. G., J. R. Ortaldo, J. Johnson, and H. F. Pross,
manuscript in preparation). Initial experiments with one donor's PBL (35 1o DM-MORRIS AND PROSS
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1+) showed that the DM-1+ cells were 33% Leu-11b+ and 50% Leu-4+, with no
Leu-19+ DM-1+ cells being detectable. Conversely, Leu-11b' cells and Leu-4+ cells
were 25% DM-l' and 2% DM-l', respectively. These preliminary findings indi-
cate that DM-1 is coexpressed on subsets ofCD16+ and CD3' cells. It is probable
that only asubset ofeach distinct population is able to respond inacytotoxic manner
to IL-2 and that DM-1 and DM-2 are unique markers for most ofthe cellular popu-
lations thatgoon tobecome LAK effectors. We have, however, observedsome heter-
ogeneity among different donors with regard to the correlation between DM-1 ex-
pression and LAK potential. In the cell depletion studies, lymphocytes from one
individual that showed only amoderate (53%) reduction in LAK activity afterdeple-
tion with DM-1, exhibited high NK activity, suggesting that the reduced effect of
the mAb on LAK generation may be explained by residual IL-2 augmentable ma-
ture NK cells.
DM-1+ and DM-2+ cells were also examined by FAGS analysis to determine pos-
sible heterogeneity of the staining population and to monitor epitope expression
throughout the course ofactivation. The FAGS histograms indicate that >85% of
cells stained by DM-1 and DM-2 express low levels of their respective epitopes, i.e.,
most cells stained with low fluorescent intensity. Further, the decrease of surface
expression of these epitopes during IL-2 activation (Fig. 6) indicates that IL-2 ex-
posure downregulates the structures recognized by DM-1 and DM-2. Whether high
orlow affinity IL-2 receptors (39) areinvolved in this regulation(directly or indirectly)
is unknown at this time. Thus, unlike the activation markers T9 (transferrin receptor,
recognized by OKT9) (40) and TLiSAI (recognized by LeoA1) (41) that become
expressed during activation, the DM-1 and DM-2 determinants are gradually lost.
The relationship between the determinants recognized by DM-1 and DM-2 ap-
pears intimate: both mAbs are capable of depleting a population of cells that, in
part, mediate NKgenerative potential, both stain cellswith a low intensity, and both
recognizedeterminants expressedat the precursor but not attheeffector level. Hence,
it would be logical to conclude that both antibodies recognize a similar, if not the
same determinant. FAGS profiles (Fig. 6) of DM-1 and DM-2 stained PBL, how-
ever, appear different and, upon further investigation using Western blot method-
ology ofPBL membrane preparations, DM-1 and DM-2 were found to recognize
38,000 and 44,000 dalton antigens, respectively. These molecular weight data rule
out the possibility that the antibodies are directed against determinants such as the
low affinity IL-2 receptor (mol wt 75,000) orthe complement (iC3b) CR3 receptor
(two chains, mol wt 165,000 and 95,000), which have been shown to be present on
LAK precursor cells (42-44). The fact that DM-1 and DM-2 antigen expression
was decreased during the incubation period also argues against this possibility. As
with Leu-11 (FcR)-positive cell depletion, removal ofCR3+ cells has a significant
effect on NK activity, which is in direct contrast with DM-1+ and DM-2+ cell
depletion.
To investigate the role ofDM-1+ and DM-2+ cells in coculture and under MLC
conditions, complement-mediated and panningdepletion were undertaken. As men-
tioned above, there are certain pitfalls encountered when forming conclusions about
anantigen-positive population basedondata from studies onthe corresponding nega-
tive populations. For example, the depleted cell may be an essential accessory cell
and not the precursor cell itself. Also, the antigen under study may be modulated732
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offthe cell surface giving the impression that the cells have been removed from the
population and aretherefore notinvolved inother typesofcytotoxicity beingexam-
ined. Finally, control depletions using other markers may actually be invalid be-
cause ofantigen modulation insteadofcell depletion. Inour experiments, depletion
ofcells bearing the CD16 marker, a known NK cell marker, removed the majority
of NK activity. Furthermore, in the case of OKT3 (CD3) depletion, reanalysis by
FAGS for residual CD3' cells with OKT3 combined with monitoring ofCD2' cells
found within this population showed that >90% ofthe CD3 and CD2 cells had been
removed. These results indicate that the depletion technique was efficient and that
down-modulation had not occurred to any appreciable extent. Since there are no
known mAbs directed tounrelated antigens exclusively on DM-1 and/or DM-2 cell
subsets, an independent assessment of DM-1' cell depletion versus modulation,
basedonmarkers, isimpossible. However, theresultsfrom thefunctional assays support
the findingthat the depletions were efficient and that modulation was not a factor.
Functional studies using DM-1 or DM-2 depleted populations in coculture (Fig.
3) and MLC (Table II) indicate that these mAbs are not involved in the generation
of the cytotoxic cells produced under these conditions. Treatment with Leu-11 or
OKT11 does affect AK generation, however, and this suggests that the cells gener-
ated during co-culture with PR-1 stem from the LGL morphologic NK pool (5).
To summarize the relationships amongthese various effector systems, we propose
a model that shows the possible activation lineages between NK, CTL, and LAK
(Fig. 8). It is well documented that a minor subset ofT lymphocytes (CD3') can,
in the presence ofexogenous IL-2, become LAK effectors (25, 26). Similarly, ma-
ture NK cells upon exposure to IL-2 can be induced to lyse many formerly NK-
resistant targets (15, 16, 36). The delineation ofthe relative contribution ofTcells,
NK cells, and their precursors in the generation of a maximal LAK response from
C D 3 '
￿
C D 3 =
CD 8'
￿
CD 8t
Cole=
CD 3 -
CD18'
FIGURE 8.
￿
Proposed model of the relationship among T cells, NK cells, and LAK cells and
their precursors. Bold face arrows represent major pathways of activation.MORRIS AND PROSS
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PBLwasamajorgoal ofthis study. From our dataweconclude thatthe contribution
ofCD3+ cells represents an insignificant component ofLAK generation, in agree-
ment with others (7, 45-47). The contribution ofNK cells, however, is significant.
Most investigators agree that NK cells, defined by morphologic, phenotypic and
cytotoxic parameters, are capable ofbecoming LAK cell effectors. However, few in-
vestigators have looked at NKprecursorcells (48, 49). Ourdata presented hereand
our unpublisheddatasupport theidea that although theresponse to IL-2 by mature
NK cells may account for the early cytotoxicity exhibited during activation, the cy-
totoxicity observed after 3-7 d ofculture may be the result ofthe activation ofNK
precursors into LAK effectors. As suggested in Fig. 8, the CD16- NK precursor
and the DM-l' LAK precursor may be identical, and the data in this report are
compatible with this possibility.
This study clearly indicates that LAK cells can be generated from a population
ofcellsthat are not mature NK cells norofaT cell phenotype. By producing mAbs
to Percoll-fractionated lymphocytes (in which maximal LAK activity canbe gener-
ated in populations containing little NK activity) we have shown that LAK effector
generation canbe markedly reducedwithouteffect on the cells responsible formedi-
atingCTL, NK, andAKactivity. The further characterization ofthisisolatedpopu-
lation ofcellswith regard tothe LAKeffectorsgenerated from theseparatedpopula-
tions is now currently under investigation and will form the basis for further study.
Summary
Separation of LAK precursor (LAKp) cells (as defined by LAK effector genera-
tionafterincubation withIL-2 for7 d)fromcellswithNK activity/LGL morphology
was achieved on Percoll gradients using a longer, slower centrifugation than that
used for optimal NK enrichment. mAb were generated using the various Percoll
fractions astheimmunizing cells and used forseparation anddepletion studies. Two
mAbs DM-1 (IgM,k) and DM-2 (IgM,k) recognizing 2-15% and 15-30% ofPBL,
respectively, abrogated a large proportion ofLAK generative potential after com-
plement depletion, but hadlittle effect on NK or LAK effector activity. Cell sorting
experiments indicated that the majority of LAKp cells are found within the DM-
1+ population and that DM-1+ cells are not simply an accessory cell required for
LAKp generation. Further, these two mAbs do not recognize cells that are respon-
sible forgenerating cytotoxicity during MLC or co-culturewith the PR-1 EBVlym-
phoblastoid cell line. Western blot analysis indicated that DM-1 and DM-2 recog-
nize a 38,000 and44,000 dalton moiety, respectively. The frequency ofcellsbearing
these antigens and the intensity of cell surface staining decreased during the 7-d
culture period, suggesting that these antibodies recognize determinants found only
at the precursorlevel. These findings indicate that cells other than NK effectors or
mature T cells arecapable ofgenerating aLAKcell response. TheseLAKprecursor
cells share a common differentiation surface antigen and are different from AK or
antigen-specific CTL precursors. The possibility exists that these cells are identical
to, or include, the NK precursor cell.
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